Literature DB >> 29312735

Prognostic factors in curatively resected pathological stage I lung adenocarcinoma.

Yikun Yang1, Yousheng Mao1, Lin Yang2, Jie He1, Shugeng Gao1, Juwei Mu1, Qi Xue1, Dali Wang1, Jun Zhao1, Yushun Gao1, Zhirong Zhang1, Ningning Ding1, Ding Yang1.   

Abstract

BACKGROUND: Patients with pathological stage I (p I) lung adenocarcinoma show variabilities in prognosis even after complete resection. The factors resulting in heterogeneities of prognosis remain controversy. The aim of this study was to identify the risk factors affecting recurrence/metastasis and survival in patients with curatively resected p I lung adenocarcinoma.
METHODS: A total of 252 patients with p I lung adenocarcinoma underwent curative resection between January 1st, 2009 to September 30th, 2011 were retrospectively reviewed to analyze the associations of recurrence and survival with the following clinicopathological variables: gender, age, cigarette smoking, family cancer history, tumor size, TNM stage, tumor differentiation, visceral pleural invasion, bronchial involvement, lymphovascular invasion, postoperative adjuvant treatment, pathological subtypes and micropapillary pattern.
RESULTS: Among those 252 patients, 48 had local recurrence or distant metastasis, the rest 204 patients had no relapse until the last follow-up. Cox univariate survival analysis revealed that tumor size (P<0.001), TNM stage [disease-free survival (DFS), P<0.001; overall survival (OS), P=0.004], tumor differentiation (P<0.001), bronchial involvement (P<0.001), lymphovascular invasion (DFS, P=0.021; OS, P=0.001) and micropapillary pattern (DFS, P<0.001; OS, P=0.003) were significantly associated with DFS and OS, while cigarette smoking (P=0.029) and pathological subtypes (P=0.041) were found to be risk factors for DFS either. In multivariate analysis, tumor differentiation (P<0.001) was an independent risk factor for both DFS and OS, TNM stage (P=0.007), bronchial involvement (P=0.004) and micropapillary pattern (P=0.001) only for DFS, while tumor size (P=0.009) and lymphovascular invasion (P=0.010) were found to be independent risk factors only for OS.
CONCLUSIONS: Tumor size, TNM stage, tumor differentiation, bronchial involvement, lymphovascular invasion and micropapillary pattern could be considered as risk factors for predicting local recurrence or distant metastasis and survival in curatively resected p I lung adenocarcinoma patients.

Entities:  

Keywords:  Lung adenocarcinoma; metastasis; prognosis; recurrence; survival

Year:  2017        PMID: 29312735      PMCID: PMC5757068          DOI: 10.21037/jtd.2017.11.65

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN: 2072-1439            Impact factor:   2.895


  23 in total

1.  Clinical impact of minimal micropapillary pattern in invasive lung adenocarcinoma: prognostic significance and survival outcomes.

Authors:  Geewon Lee; Ho Yun Lee; Ji Yun Jeong; Joungho Han; Min Jae Cha; Kyung Soo Lee; Jhingook Kim; Young Mog Shim
Journal:  Am J Surg Pathol       Date:  2015-05       Impact factor: 6.394

2.  Prediction and prognostic factors of post-recurrence survival in recurred patients with early-stage NSCLC who underwent complete resection.

Authors:  Pil Jo Choi; Sang Seok Jeong; Sung Sil Yoon
Journal:  J Thorac Dis       Date:  2016-01       Impact factor: 2.895

3.  Influence of age and IB status after resection of node-negative non-small cell lung cancer.

Authors:  Matthew J Schuchert; Omar Awais; Ghulam Abbas; Zachary D Horne; Katie S Nason; Arjun Pennathur; André P Souza; Jill M Siegfried; David O Wilson; James D Luketich; Rodney J Landreneau
Journal:  Ann Thorac Surg       Date:  2012-03       Impact factor: 4.330

4.  The novel histologic International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification system of lung adenocarcinoma is a stage-independent predictor of survival.

Authors:  Arne Warth; Thomas Muley; Michael Meister; Albrecht Stenzinger; Michael Thomas; Peter Schirmacher; Philipp A Schnabel; Jan Budczies; Hans Hoffmann; Wilko Weichert
Journal:  J Clin Oncol       Date:  2012-03-05       Impact factor: 44.544

Review 5.  Evolving concepts in the pathology and computed tomography imaging of lung adenocarcinoma and bronchioloalveolar carcinoma.

Authors:  William D Travis; Kavita Garg; Wilbur A Franklin; Ignacio I Wistuba; Bradley Sabloff; Masayuki Noguchi; Ryutaro Kakinuma; Maureen Zakowski; Michelle Ginsberg; Robert Padera; Francine Jacobson; Bruce E Johnson; Fred Hirsch; Elizabeth Brambilla; Douglas B Flieder; Kim R Geisinger; Frederik Thunnisen; Keith Kerr; David Yankelevitz; Teri J Franks; Jeffrey R Galvin; Douglas W Henderson; Andrew G Nicholson; Philip S Hasleton; Victor Roggli; Ming-Sound Tsao; Federico Cappuzzo; Madeline Vazquez
Journal:  J Clin Oncol       Date:  2005-05-10       Impact factor: 44.544

Review 6.  Visceral pleural invasion remains a size-independent prognostic factor in stage I non-small cell lung cancer.

Authors:  He Huang; Ting Wang; Bin Hu; Changchuan Pan
Journal:  Ann Thorac Surg       Date:  2015-02-20       Impact factor: 4.330

7.  Pulmonary adenocarcinoma with a micropapillary pattern: a clinicopathological, immunophenotypic and molecular analysis.

Authors:  Jing Zhang; Zhiyong Liang; Jie Gao; Yufeng Luo; Tonghua Liu
Journal:  Histopathology       Date:  2011-12       Impact factor: 5.087

8.  Prognostic Impact of Multiple Clinicopathologic Risk Factors and c-MET Overexpression in Patients Who Have Undergone Resection of Stage IB Non-Small-Cell Lung Cancer.

Authors:  In-Ho Kim; In Hee Lee; Ji Eun Lee; Sook Hee Hong; Tae-Jung Kim; Kyo-Young Lee; Young Kyoon Kim; Seung Joon Kim; Sook Whan Sung; Jae Kil Park; Ie Ryung Yoo; Yeon Sil Kim; Jung-Oh Kim; Jin Hyoung Kang
Journal:  Clin Lung Cancer       Date:  2016-02-02       Impact factor: 4.785

9.  Histopathological features and prognostic significance of the micropapillary pattern in lung adenocarcinoma.

Authors:  Kazunori Kamiya; Yuichiro Hayashi; Junya Douguchi; Akinori Hashiguchi; Taketo Yamada; Yotaro Izumi; Masazumi Watanabe; Masafumi Kawamura; Hirohisa Horinouchi; Naoki Shimada; Koichi Kobayashi; Michiie Sakamoto
Journal:  Mod Pathol       Date:  2008-05-30       Impact factor: 7.842

10.  Lung adenocarcinoma: modification of the 2004 WHO mixed subtype to include the major histologic subtype suggests correlations between papillary and micropapillary adenocarcinoma subtypes, EGFR mutations and gene expression analysis.

Authors:  Noriko Motoi; Janos Szoke; Gregory J Riely; Venkatraman E Seshan; Mark G Kris; Valerie W Rusch; William L Gerald; William D Travis
Journal:  Am J Surg Pathol       Date:  2008-06       Impact factor: 6.394

View more
  3 in total

1.  Prognostic factors of patients with pathologic stage I lung adenocarcinoma.

Authors:  Ying-Yi Chen; Tsai-Wang Huang
Journal:  J Thorac Dis       Date:  2018-04       Impact factor: 2.895

2.  Visceral Pleural Invasion in Pulmonary Adenocarcinoma: Differences in CT Patterns between Solid and Subsolid Cancers.

Authors:  Benedikt H Heidinger; Ursula Schwarz-Nemec; Kevin R Anderson; Constance de Margerie-Mellon; Antonio C Monteiro Filho; Yigu Chen; Marius E Mayerhoefer; Paul A VanderLaan; Alexander A Bankier
Journal:  Radiol Cardiothorac Imaging       Date:  2019-08-29

3.  Computational detection of a genome instability-derived lncRNA signature for predicting the clinical outcome of lung adenocarcinoma.

Authors:  Chen-Rui Guo; Yan Mao; Feng Jiang; Chen-Xia Juan; Guo-Ping Zhou; Ning Li
Journal:  Cancer Med       Date:  2021-12-05       Impact factor: 4.452

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.